ATI-9242
Product
Braeburn Pharmaceuticals, Inc.
Total Payments
$93,969
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $93,969 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $93,969 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| BB-ATI9242-001 | Braeburn Pharmaceuticals, Inc. | $93,969 | 0 |
Top Doctors Receiving Payments for ATI-9242
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Detroit, MI | $93,969 | 1 |
Ad
Manufacturing Companies
- Braeburn Pharmaceuticals, Inc. $93,969
Product Information
- Type Product
- Total Payments $93,969
- Total Doctors 0
- Transactions 1
About ATI-9242
ATI-9242 is a product associated with $93,969 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is Braeburn Pharmaceuticals, Inc..
Payment data is available from 2017 to 2017. In 2017, $93,969 was paid across 1 transactions to 0 doctors.
The most common payment nature for ATI-9242 is "Unspecified" ($93,969, 100.0% of total).
ATI-9242 is associated with 1 research study, including "BB-ATI9242-001" ($93,969).